[Retracted] Investigation on Risk Stratification and the Prognostic Value of hs‐TnT Combined with MMP‐2 in Patients with Acute Coronary Syndrome

Ying Li, Li Li, Kun Wang, Pengtao Wu, Yijie Cui

Open source

DOI
10.1155/2021/1040171
Published
2021-01
Container
BioMed Research International
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2021/1040171,
  title = {[Retracted] Investigation on Risk Stratification and the Prognostic Value of hs‐TnT Combined with MMP‐2 in Patients with Acute Coronary Syndrome},
  author = {Ying Li and Li Li and Kun Wang and Pengtao Wu and Yijie Cui},
  year = {2021},
  journal = {BioMed Research International},
  doi = {10.1155/2021/1040171},
  url = {https://doi.org/10.1155/2021/1040171}
}

RIS

TY  - JOUR
TI  - [Retracted] Investigation on Risk Stratification and the Prognostic Value of hs‐TnT Combined with MMP‐2 in Patients with Acute Coronary Syndrome
AU  - Ying Li
AU  - Li Li
AU  - Kun Wang
AU  - Pengtao Wu
AU  - Yijie Cui
PY  - 2021
JO  - BioMed Research International
DO  - 10.1155/2021/1040171
UR  - https://doi.org/10.1155/2021/1040171
ER  - 

APA

Li, Y., Li, L., Wang, K., Wu, P., & Cui, Y. (2021). [Retracted] Investigation on Risk Stratification and the Prognostic Value of hs‐TnT Combined with MMP‐2 in Patients with Acute Coronary Syndrome. BioMed Research International. https://doi.org/10.1155/2021/1040171

Source records